← Axon Enterprise overview

Axon Enterprise vs Parsons: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Axon Enterprise Inc. (AXON)

Q3 2026
▲3▼1

Axon's record Q2 and raised outlook drive growth story

  • Record Q2 revenue and raised full-year outlook Axon reported Q2 revenue of $904 million, up 35% year over year, and raised its 2026 revenue growth guidance to 32-34% from 30-32%. This shows strong demand for its products and boosts investor confidence in future growth.

    This is the core new event that directly lifts Axon's growth prospects and stock price.

  • Strong bookings and recurring revenue Future contracted bookings jumped 41% to $15.1 billion, and annual recurring revenue rose 39% to $1.6 billion with net revenue retention at 126%. This means customers are committing to more Axon products and services, providing predictable future income.

    It highlights the underlying demand strength that supports the raised outlook and long-term growth.

  • Q2 earnings miss and margin pressure Despite revenue growth, adjusted earnings per share of $1.88 missed the consensus estimate of $1.89, and net income fell to $29 million from $36 million a year earlier. This shows costs are rising and profitability is under pressure, which can weigh on the stock.

    It provides the main counterweight to the positive revenue news and explains why the stock dropped after earnings.

  • New Taser product (Apollo) on track Axon is close to finalizing its Apollo cartridge, a new Taser designed to outperform a nine-millimeter bullet, with a target release by next winter. This innovation could open new markets and drive future sales.

    It is a new product development that supports the long-term growth narrative beyond current results.

August 2026
▲3▼1

Axon's record Q2 and raised outlook drive growth story

  • Record Q2 revenue and raised full-year outlook Axon reported Q2 revenue of $904 million, up 35% year over year, and raised its 2026 revenue growth guidance to 32-34% from 30-32%. This shows strong demand for its products and boosts investor confidence in future growth.

    This is the core new event that directly lifts Axon's growth prospects and stock price.

  • Strong bookings and recurring revenue Future contracted bookings jumped 41% to $15.1 billion, and annual recurring revenue rose 39% to $1.6 billion with net revenue retention at 126%. This means customers are committing to more Axon products and services, providing predictable future income.

    It highlights the underlying demand strength that supports the raised outlook and long-term growth.

  • Q2 earnings miss and margin pressure Despite revenue growth, adjusted earnings per share of $1.88 missed the consensus estimate of $1.89, and net income fell to $29 million from $36 million a year earlier. This shows costs are rising and profitability is under pressure, which can weigh on the stock.

    It provides the main counterweight to the positive revenue news and explains why the stock dropped after earnings.

  • New Taser product (Apollo) on track Axon is close to finalizing its Apollo cartridge, a new Taser designed to outperform a nine-millimeter bullet, with a target release by next winter. This innovation could open new markets and drive future sales.

    It is a new product development that supports the long-term growth narrative beyond current results.

Latest
▲3▼1

Axon's record Q2 and raised outlook drive growth story

  • Record Q2 revenue and raised full-year outlook Axon reported Q2 revenue of $904 million, up 35% year over year, and raised its 2026 revenue growth guidance to 32-34% from 30-32%. This shows strong demand for its products and boosts investor confidence in future growth.

    This is the core new event that directly lifts Axon's growth prospects and stock price.

  • Strong bookings and recurring revenue Future contracted bookings jumped 41% to $15.1 billion, and annual recurring revenue rose 39% to $1.6 billion with net revenue retention at 126%. This means customers are committing to more Axon products and services, providing predictable future income.

    It highlights the underlying demand strength that supports the raised outlook and long-term growth.

  • Q2 earnings miss and margin pressure Despite revenue growth, adjusted earnings per share of $1.88 missed the consensus estimate of $1.89, and net income fell to $29 million from $36 million a year earlier. This shows costs are rising and profitability is under pressure, which can weigh on the stock.

    It provides the main counterweight to the positive revenue news and explains why the stock dropped after earnings.

  • New Taser product (Apollo) on track Axon is close to finalizing its Apollo cartridge, a new Taser designed to outperform a nine-millimeter bullet, with a target release by next winter. This innovation could open new markets and drive future sales.

    It is a new product development that supports the long-term growth narrative beyond current results.

Q2 2026
▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

  • AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.

    This is the fundamental growth driver behind the stock's move and a new guidance raise.

  • Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.

    Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.

  • Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.

    This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.

  • Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.

    This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

June 2026
▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

  • AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.

    This is the fundamental growth driver behind the stock's move and a new guidance raise.

  • Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.

    Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.

  • Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.

    This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.

  • Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.

    This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

  • AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.

    This is the fundamental growth driver behind the stock's move and a new guidance raise.

  • Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.

    Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.

  • Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.

    This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.

  • Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.

    This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

Parsons Corp (PSN)

Q3 2026
▲2▼2

Parsons Slashes 2026 Guidance, Triggers 38% Plunge and Investigations

  • 2026 Guidance Cut and Q2 Miss Parsons cut full-year 2026 revenue and profit guidance and reported a surprise net loss, sending shares down 38%. The company blamed divestitures and delayed awards, but investors fear weaker future earnings.

    This is the main new event that directly caused the stock to plummet and changes the earnings outlook.

  • Securities Investigations Launched Multiple law firms are investigating whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or lawsuits, further pressuring the stock.

    New investigations are a direct consequence of the guidance cut and add a new risk factor for investors.

  • New Army Cyber Contract Parsons won a contract to provide cybersecurity for the U.S. Army Research Lab, deepening its role in high-value defense tech. This supports long-term revenue but is overshadowed by the guidance cut.

    This is a new positive development that shows underlying demand, but its impact is muted by the larger negative news.

  • Industrial Modernization Demand Parsons highlighted a $169.5M Army contract and growing demand for industrial base modernization. This shows a healthy pipeline, but near-term execution issues and guidance cut dominate investor sentiment.

    This new contract and demand signal are positive but not enough to offset the negative guidance revision.

July 2026
▲2▼2

Parsons Slashes 2026 Guidance, Triggers 38% Plunge and Investigations

  • 2026 Guidance Cut and Q2 Miss Parsons cut full-year 2026 revenue and profit guidance and reported a surprise net loss, sending shares down 38%. The company blamed divestitures and delayed awards, but investors fear weaker future earnings.

    This is the main new event that directly caused the stock to plummet and changes the earnings outlook.

  • Securities Investigations Launched Multiple law firms are investigating whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or lawsuits, further pressuring the stock.

    New investigations are a direct consequence of the guidance cut and add a new risk factor for investors.

  • New Army Cyber Contract Parsons won a contract to provide cybersecurity for the U.S. Army Research Lab, deepening its role in high-value defense tech. This supports long-term revenue but is overshadowed by the guidance cut.

    This is a new positive development that shows underlying demand, but its impact is muted by the larger negative news.

  • Industrial Modernization Demand Parsons highlighted a $169.5M Army contract and growing demand for industrial base modernization. This shows a healthy pipeline, but near-term execution issues and guidance cut dominate investor sentiment.

    This new contract and demand signal are positive but not enough to offset the negative guidance revision.

Latest
▲2▼2

Parsons Slashes 2026 Guidance, Triggers 38% Plunge and Investigations

  • 2026 Guidance Cut and Q2 Miss Parsons cut full-year 2026 revenue and profit guidance and reported a surprise net loss, sending shares down 38%. The company blamed divestitures and delayed awards, but investors fear weaker future earnings.

    This is the main new event that directly caused the stock to plummet and changes the earnings outlook.

  • Securities Investigations Launched Multiple law firms are investigating whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or lawsuits, further pressuring the stock.

    New investigations are a direct consequence of the guidance cut and add a new risk factor for investors.

  • New Army Cyber Contract Parsons won a contract to provide cybersecurity for the U.S. Army Research Lab, deepening its role in high-value defense tech. This supports long-term revenue but is overshadowed by the guidance cut.

    This is a new positive development that shows underlying demand, but its impact is muted by the larger negative news.

  • Industrial Modernization Demand Parsons highlighted a $169.5M Army contract and growing demand for industrial base modernization. This shows a healthy pipeline, but near-term execution issues and guidance cut dominate investor sentiment.

    This new contract and demand signal are positive but not enough to offset the negative guidance revision.

Q2 2026
▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.

June 2026
▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.

▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.

© 2026 MarketIVWhy